Skip to main content
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.04
-0.33 (-2.02%)
At close: Apr 28, 2026, 4:00 PM EDT
16.04
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Aurinia Pharmaceuticals Revenue

In the year 2025, Aurinia Pharmaceuticals had annual revenue of $283.06M with 20.38% growth. Aurinia Pharmaceuticals had revenue of $77.11M in the quarter ending December 31, 2025, with 28.81% growth.

Revenue (ttm)
$283.06M
Revenue Growth
+20.38%
P/S Ratio
7.40
Revenue / Employee
$2,211,367
Employees
128
Market Cap
2.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025283.06M47.92M20.38%
Dec 31, 2024235.13M59.62M33.97%
Dec 31, 2023175.51M41.48M30.95%
Dec 31, 2022134.03M88.43M193.89%
Dec 31, 202145.61M-4.51M-9.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sarepta Therapeutics 2.20B
Adaptive Biotechnologies 276.98M
Stoke Therapeutics 184.42M
Zymeworks 105.97M
Ascentage Pharma Group International 82.08M
Mesoblast 65.38M
Ocular Therapeutix 51.95M
Capricor Therapeutics 11.13M
Revenue Rankings

AUPH News

More News